The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 30, 2019

Filed:

May. 19, 2016
Applicant:

Memorial Sloan-kettering Cancer Center, New York, NY (US);

Inventors:

Stuart Chambers, New York, NY (US);

Lorenz Studer, New York, NY (US);

Zehra Dincer, New York, NY (US);

Bastian Zimmer, New York, NY (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/0793 (2010.01); A61K 35/12 (2015.01); C07D 243/36 (2006.01); C07D 211/00 (2006.01); C07D 307/32 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0619 (2013.01); A61K 35/12 (2013.01); C07D 211/00 (2013.01); C07D 243/36 (2013.01); C07D 307/32 (2013.01); C12N 2501/119 (2013.01); C12N 2501/13 (2013.01); C12N 2501/155 (2013.01); C12N 2501/41 (2013.01); C12N 2501/415 (2013.01); C12N 2501/727 (2013.01); C12N 2501/734 (2013.01); C12N 2501/998 (2013.01); C12N 2501/999 (2013.01); C12N 2506/02 (2013.01); C12N 2506/45 (2013.01);
Abstract

Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.


Find Patent Forward Citations

Loading…